Literature DB >> 6389376

A new model-independent physiological approach to study hepatic drug clearance and its applications.

W L Chiou.   

Abstract

After entering the liver a drug molecule is removed by two competitive processes: (a) blood flow to carry it away intact from liver and (b) elimination by hepatic enzyme(s). The relative magnitude of the overall force or efficiency of these two processes will statistically decide its probability for elimination, i.e., extraction ratio (E). Blood flow rate is chosen to represent the force due to blood flow, and the force due to hepatic elimination can then be simply calculated in terms of blood flow per unit time. Under linear conditions any changes in either force can be used to predict new E. Binding in blood, permeability across hepatocellular membrane and intrinsic enzyme activity will affect the hepatic elimination force. The approach employed has virtually made no prior assumptions regarding distribution profiles of drug, enzymes, sinusoids and intracellular bindings as well as drug permeability. Bioavailability predictions upon changes in hepatic flow or protein binding are consistent with most reported data. It can explain potential differences in the fate of drug pre-equilibrated or not pre-equilibrated with blood before entering the liver and also that of metabolite performed or not performed in liver. Importance of erythrocytes as potential elimination barriers in hepatic first-pass effect and existence of both transverse and longitudinal (not considered in previous hepatic models) drug concentration gradients in the liver are emphasized. Applications to studies of instantaneous, time-averaged, beta and intrinsic clearances, as well as hepatic transit time and nonlinear kinetics are discussed. The present simple dynamic approach can also successfully predict the quantitative correlation between renal clearance and changes in urine flow and/or pH for many drugs in humans and animals. Using steady-state input conditions the present derived equations can be obtained thus adding the mathematical validity of the approach.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6389376

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Ther Toxicol        ISSN: 0174-4879


  8 in total

1.  Effect of erythrocytes on the hepatic distribution kinetics of antipyrine.

Authors:  Selma Sahin; Malcolm Rowland
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2004 Jan-Mar       Impact factor: 2.441

Review 2.  The phenomenon and rationale of marked dependence of drug concentration on blood sampling site. Implications in pharmacokinetics, pharmacodynamics, toxicology and therapeutics (Part II).

Authors:  W L Chiou
Journal:  Clin Pharmacokinet       Date:  1989-10       Impact factor: 6.447

3.  Effect of a change in the luminal perfusion rate on intestinal drug absorption studied by a simple unified organ clearance approach.

Authors:  W L Chiou
Journal:  Pharm Res       Date:  1989-12       Impact factor: 4.200

4.  Investigation of distribution and elimination of terbutaline sulfate in the perfused rat liver preparation.

Authors:  Selma Sahin; Yasemin Karabey
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2010-09       Impact factor: 2.441

5.  Hepatic elimination: effect of blood flow on hepatic extraction.

Authors:  W L Chiou
Journal:  J Pharmacokinet Biopharm       Date:  1987-12

6.  Erythrocytes as barriers for drug elimination in the isolated rat liver. II. Propranolol.

Authors:  H J Lee; W L Chiou
Journal:  Pharm Res       Date:  1989-10       Impact factor: 4.200

7.  Erythrocytes as barriers for drug elimination in the isolated rat liver. I. Doxorubicin.

Authors:  H J Lee; W L Chiou
Journal:  Pharm Res       Date:  1989-10       Impact factor: 4.200

8.  Correlation of unbound plasma clearances of fifteen extensively metabolized drugs between humans and rats.

Authors:  W L Chiou; F H Hsu
Journal:  Pharm Res       Date:  1988-10       Impact factor: 4.200

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.